ng-nitroarginine methyl ester has been researched along with Kidney Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pertijs, J; Rongen, GA; Thijs, AM; van den Broek, PH; van der Graaf, WT; van Herpen, CM; Verweij, V | 1 |
1 other study(ies) available for ng-nitroarginine methyl ester and Kidney Neoplasms
Article | Year |
---|---|
Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertension.
Topics: Acetylcholine; Adult; Aged; Angiogenesis Inhibitors; Animals; Carcinoma, Renal Cell; Endothelium, Vascular; Forearm; Humans; Hypertension; Indoles; Kidney Neoplasms; Male; Mesenteric Arteries; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Pyrroles; Rats; Regional Blood Flow; Sunitinib; Vascular Endothelial Growth Factor A; Vasodilation; Vasodilator Agents | 2015 |